Ticker brief
DFTX DEFINIUM THERAPEUTICS INC
Consumer, Non-cyclical · Biotechnology
last close
$35.67
1 day
-0.9%
14 days
-3.3%
mkt cap
$5.9B
signals 14d
12
authors 14d
6
crowd 14d
-0.3σ
Options inteloptions-surface reads · latest available day per source
| metric | reading | context |
|---|---|---|
| IV — ATM 30d | 59% cheap · 1 pctile own 1y | IV/HV 0.94× (as of 2026-10-21) |
| Skew — 25Δ RR 30d | -0.004 51 pctile own 1y | balanced vs own range |
| Net dealer OI (NDOI) | +3.01 elevated | 5-session Δ -0.13 (as of 2026-07-06) |
| OI alarm | quiet | last alarm 2026-07-13 (z=5.8) |
Sentiment — last 14 days
daily mean sentiment, 2026-10-07 → 2026-10-16 · now +0.65 (−1 bearish … +1 bullish)
Who spoke6
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @Biotech2k1 | A | +1.11 | 7 | +0.34 |
| @Source_options | C | +0.67 | 1 | +0.35 |
| @zohmbastic | C | -2.94 | 1 | +0.40 |
| @Brad_E_Schulz | C | · | 1 | +0.30 |
| @PrismMarketView | C | · | 1 | +0.10 |
| @Tickeron | C | +1.53 | 1 | +0.15 |
Recent signals12of 12 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-10-16 | @Biotech2k1 | +0.65 | Initiated or added a small DFTX position. — The author says they nibbled a little DFTX. | +11.1% | tweet ↗ |
| 2026-10-12 | @Biotech2k1 | +0.45 | Discloses small purchases and willingness to sell if valuations become excessive. | +1.3% | tweet ↗ |
| 2026-10-12 | @Biotech2k1 | -0.35 | Sell MIRM into the rally, then reduce SMMT and DFTX. — States a concrete sequence for selling MIRM and subsequently reducing SMMT and DFTX. | +1.3% | tweet ↗ |
| 2026-10-11 | @Tickeron | +0.15 | Details a 2% consolidation while highlighting upcoming Phase 3 readouts | -3.3% | tweet ↗ |
| 2026-10-09 | @Biotech2k1 | +0.20 | Added MDGL while retaining other names as potential sources of cash. — Explicitly adds MDGL and explains a value-focused portfolio funding plan. | -3.3% | tweet ↗ |
| 2026-10-09 | @Biotech2k1 | +0.20 | A standing GTC sell order for DFTX is close to executing. — Discloses an active standing order intended to sell DFTX. | -3.3% | tweet ↗ |
| 2026-10-09 | @PrismMarketView | +0.10 | Reviews mental-health stocks, sector milestones, performance and clinical risks. | -3.3% | tweet ↗ |
| 2026-10-09 | @Brad_E_Schulz | +0.30 | Reports intraday sector breadth and qualifying biotech movers. | -3.3% | tweet ↗ |
| 2026-10-09 | @zohmbastic | +0.40 | JPMorgan initiated Definium Therapeutics at Overweight with an $84 target. | -3.3% | tweet ↗ |
| 2026-10-08 | @Biotech2k1 | +0.65 | Author reports adding to an existing DFTX position below 33. | +4.4% | tweet ↗ |
| 2026-10-08 | @Biotech2k1 | +0.55 | Reports small purchases in four biotech names. | +4.4% | tweet ↗ |
| 2026-10-07 | @Source_options | +0.35 | Presents five stocks as a two-year portfolio watchlist at current prices. | +1.7% | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.